Perampanel: newly approved, novel antiepileptic medication for partial-onset seizures.
Department of Neurology, Barrow Neurological Institute, Phoenix, AZ 85013, USA.
Vladimir
V
Shvarts
Steve
S
Chung
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D055815:Young Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005500:Follow-Up Studies; D007391:International Cooperation; D008137:Longitudinal Studies; D009570:Nitriles; D011728:Pyridones / Q000627:therapeutic use; D012640:Seizures / Q000188:drug therapy; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D017326:Clinical Trials, Phase III as Topic
D000927:Anticonvulsants; D009570:Nitriles; C551441:perampanel; D011728:Pyridones